Skip to main content
. 2023 May 4;15(9):2613. doi: 10.3390/cancers15092613

Figure 4.

Figure 4

Immune niche of GSC. Via releasing macrophage colony-stimulating factor (M-CSF) and TGF-β, GSC could promote M2-polarization of TAM; by secreting hypoxia-related galectin-3, GSCs suppress proliferation of effector T cells; hypoxia enhances the PD-L1 level of activated T cells and induces interleukin-6-activated STAT3 to impede cytotoxity of CTLs (cytotoxic T lymphocytes). The above described processes all contribute to immune suppression and decreased survival of GBM patients.